1. Home
  2. EXEL vs ARMK Comparison

EXEL vs ARMK Comparison

Compare EXEL & ARMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • ARMK
  • Stock Information
  • Founded
  • EXEL 1994
  • ARMK 1959
  • Country
  • EXEL United States
  • ARMK United States
  • Employees
  • EXEL N/A
  • ARMK N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • ARMK Restaurants
  • Sector
  • EXEL Health Care
  • ARMK Consumer Discretionary
  • Exchange
  • EXEL Nasdaq
  • ARMK Nasdaq
  • Market Cap
  • EXEL 10.4B
  • ARMK 10.1B
  • IPO Year
  • EXEL 2000
  • ARMK 2013
  • Fundamental
  • Price
  • EXEL $38.12
  • ARMK $37.58
  • Analyst Decision
  • EXEL Buy
  • ARMK Strong Buy
  • Analyst Count
  • EXEL 23
  • ARMK 9
  • Target Price
  • EXEL $44.10
  • ARMK $45.67
  • AVG Volume (30 Days)
  • EXEL 3.0M
  • ARMK 2.3M
  • Earning Date
  • EXEL 11-04-2025
  • ARMK 11-17-2025
  • Dividend Yield
  • EXEL N/A
  • ARMK 1.12%
  • EPS Growth
  • EXEL 81.76
  • ARMK 3.13
  • EPS
  • EXEL 2.08
  • ARMK 1.36
  • Revenue
  • EXEL $2,230,005,000.00
  • ARMK $17,874,782,000.00
  • Revenue This Year
  • EXEL $9.14
  • ARMK $9.17
  • Revenue Next Year
  • EXEL $12.51
  • ARMK $5.82
  • P/E Ratio
  • EXEL $18.32
  • ARMK $27.68
  • Revenue Growth
  • EXEL 10.73
  • ARMK 4.02
  • 52 Week Low
  • EXEL $31.90
  • ARMK $29.92
  • 52 Week High
  • EXEL $49.62
  • ARMK $44.49
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 46.88
  • ARMK 36.46
  • Support Level
  • EXEL $33.76
  • ARMK $39.50
  • Resistance Level
  • EXEL $40.63
  • ARMK $40.26
  • Average True Range (ATR)
  • EXEL 1.31
  • ARMK 0.80
  • MACD
  • EXEL 0.07
  • ARMK -0.21
  • Stochastic Oscillator
  • EXEL 63.54
  • ARMK 5.56

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About ARMK Aramark

Aramark, founded in 1936 and headquartered in Philadelphia, Pennsylvania, operates as a food service company providing facility management and workplace solutions. The company primarily generates revenue from its North American food and support services segment, serving various clients including schools, healthcare facilities, and entertainment venues.

Share on Social Networks: